AT385504T
B7-related nucleic acids and polypeptides and their uses for immunomodulation
Abstract
This record has no abstract on file.
Term
Term ended
Expired 6 June 2021, 5.3 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
60 members in 11 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 20981100 | United States of America | P | |
| 20981100 | United States of America | P | |
| 27210701 | United States of America | P | |
| 27210701 | United States of America | P | |
| 209811P | – | – | – |
| 272107P | – | – | – |
| US20000209811P | – | – | – |
| US20010272107P | – | – | – |
Members60
| Document | Office | Kind | |
|---|---|---|---|
| CA2412377A1 | Canada | A1 | |
| WO0194413A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU7528501A | Australia | A | |
| AU7528501A | Australia | A | |
| US2002095024A1 | United States of America | A1 | |
| WO0194413A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CA2449890A1 | Canada | A1 | |
| WO02099119A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO02099119A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002312387A1 | Australia | A1 | |
| US2003031675A1 | United States of America | A1 | |
| EP1292619A2 | European Patent Office (EPO) | A2 | |
| MXPA02012106A | Mexico | A | |
| IL152886A0 | Israel | A0 | |
| IL152886D0 | Israel | D0 | |
| JP2004500863A | Japan | A | |
| WO02099119A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO02099119A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1519942A2 | European Patent Office (EPO) | A2 | |
| US2005208525A1 | United States of America | A1 | |
| EP1519942A4 | European Patent Office (EPO) | A4 | |
| US6965018B2 | United States of America | B2 | |
| US2006140937A1 | United States of America | A1 | |
| US2006159685A1 | United States of America | A1 | |
| US7279567B2 | United States of America | B2 | |
| EP1292619B1 | European Patent Office (EPO) | B1 | |
| AT385504TThis record | Austria | T | |
| ATE385504T1 | Austria | T1 | |
| EP1892251A2 | European Patent Office (EPO) | A2 | |
| DE60132699D1 | Germany | D1 | |
| US7358354B2 | United States of America | B2 | |
| US7368554B2 | United States of America | B2 | |
| ES2300340T3 | Spain | T3 | |
| EP1892251A3 | European Patent Office (EPO) | A3 | |
| DE60132699T2 | Germany | T2 | |
| EP2080766A1 | European Patent Office (EPO) | A1 | |
| US2009215995A1 | United States of America | A1 | |
| US2010125127A1 | United States of America | A1 | |
| US7723479B2 | United States of America | B2 | |
| US2010136575A1 | United States of America | A1 | |
| US7807786B2 | United States of America | B2 | |
| US2011294162A1 | United States of America | A1 | |
| US8080636B2 | United States of America | B2 | |
| US2012329990A1 | United States of America | A1 | |
| US8354513B2 | United States of America | B2 | |
| US2013144042A1 | United States of America | A1 | |
| US8664360B2 | United States of America | B2 | |
| US8674076B2 | United States of America | B2 | |
| US2014154260A1 | United States of America | A1 | |
| US2014194598A1 | United States of America | A1 | |
| US9399052B2 | United States of America | B2 | |
| US9409970B2 | United States of America | B2 | |
| US2016340408A1 | United States of America | A1 | |
| US2017190759A1 | United States of America | A1 | |
| US10308702B2 | United States of America | B2 | |
| US2019248868A1 | United States of America | A1 | |
| US10400023B2 | United States of America | B2 | |
| US2020079835A1 | United States of America | A1 | |
| US10590183B2 | United States of America | B2 | |
| US2020369744A1 | United States of America | A1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Publication, DOCDB
- 385504
- Publication, EPODOC
- AT385504T
- Application
- 1941978
- Application, DOCDB
- 01941978
- Application, EPODOC
- AT20010941978T
Titles2
- German
- NUKLEINSÄUREN UND POLYPEPTIDE, DIE SICH AUF B7 BEZIEHEN UND IHRE VERWENDUNGEN ZUR IMMUNMODULIERUNG
- English
- NUCLEIC ACIDS AND POLYPEPTIDES RELATING TO B7 AND THEIR USES FOR IMMUNOMODULATION
Classification
- CPC, 36
- C07K14/70532
- A61K38/00
- C07K16/2827
- C07K2317/56
- C07K2319/00
- C07K2319/30
- Y10S435/81
- C07K2317/76
- A61P1/04
- A61P1/16
- A61P11/00
- A61P11/06
- A61P17/02
- A61P17/06
- A61P19/02
- A61P19/04
- A61P21/00
- A61P21/04
- A61P25/28
- A61P27/02
- A61P29/00
- A61P31/12
- A61P31/14
- A61P31/16
- A61P31/18
- A61P31/20
- A61P31/22
- A61P35/00
- A61P37/04
- A61P37/06
- A61P43/00
- A61P5/14
- A61P7/04
- A61P7/06
- A61P9/10
- A61P3/10
- IPC, 53
- A01K67 027
- C07K14 705
- A61K35 12
- A61K35 64
- A61K35 74
- A61K36 00
- A61K38 00
- A61K38 17
- A61K39 395
- A61K48 00
- A61P1 04
- A61P1 16
- A61P3 10
- A61P5 14
- A61P7 04
- A61P7 06
- A61P9 10
- A61P11 00
- A61P11 06
- A61P17 02
- A61P17 06
- A61P19 02
- A61P19 04
- A61P21 00
- A61P21 04
- A61P25 28
- A61P27 02
- A61P29 00
- A61P31 12
- A61P31 14
- A61P31 16
- A61P31 18
- A61P31 20
- A61P31 22
- A61P35 00
- A61P37 04
- A61P37 06
- A61P43 00
- C07K14 47
- C07K16 18
- C07K16 28
- C07K19 00
- C12N1 15
- C12N1 19
- C12N1 21
- C12N5 10
- C12N15 02
- C12N15 09
- C12N15 12
- C12P21 08
- C12Q1 68
- G01N33 53
- G01N33 566